Philippines Moves to Ban Open-System Vape Cartridges and Uncertified E-Liquids, Removes Several Devices from Compliance List

Oct.21.2025
Philippines Moves to Ban Open-System Vape Cartridges and Uncertified E-Liquids, Removes Several Devices from Compliance List
DTI plans nationwide ban on open system pods and unlicensed e-liquids to ensure consumer safety and health.

Key points

 

  • The Department of Trade and Industry (DTI) in the Philippines is considering a nationwide ban on open pod systems and unregistered e-liquids, covering all aspects of production, importation, distribution, and retail. 
  • They have removed open pod systems from the list of permitted products to ensure that only compliant e-cigarette products enter the market and retail networks.
  •  This decision comes after the Philippine Drug Enforcement Agency (PDEA) reported the detection of synthetic cannabinoids, shifting regulatory focus towards ingredient risks and protection of youth through evidence-based enforcement. 
  • The DTI is planning to issue a regulatory ban in accordance with RA 11900, establishing a standardized list of permits and reporting channels.

 


 

 2Firsts,on October 20, 2025——According to an announcement on the official website of the Department of Trade and Industry (DTI) in the Philippines the DTI is intensifying efforts to regulate the production, importation, distribution, and sale of vape open pods and uncertified e-liquids. The goal of these measures is to reduce consumer safety and health risks.

 

The Department of Trade and Industry (DTI) has removed a specific model of open system pod from the scope of the Philippine Standard (PS) certification to ensure that only products that meet the specified standards can be sold to the public.

 

At the same time, e-cigarette company Phantom Vape Group, Inc. has voluntarily reduced the coverage of its PS Certificate No. Q-00002, excluding open-system models under the VAGEND brand such as the VPRIME Device, XLIM PRO 2 Device, NEXLIM Device, XLIM GO Device, and XLIM SQ PRO 2 Device. This means that the mentioned products are no longer authorized for production, import, distribution, or retail within the Philippines.

 

According to reports, DTI's move also responds to concerns in society about e-cigarette products suspected of containing synthetic cannabinoids. The Philippine Drug Enforcement Agency (PDEA) recently detected synthetic chemical substances in "Tuklaw" tobacco that can mimic the effects of marijuana, prompting regulatory alerts.

 

The Office for the Special Mandate on Vaporized Nicotine and Non-Nicotine Products, their Devices, and Novel Tobacco Products, a subordinate agency of the Department of Trade and Industry (DTI), is finalizing regulatory documents to institutionalize the nationwide ban on open-pod systems and uncertified e-liquids.

 

The Department of Trade and Industry (DTI) emphasizes that it will continue to fulfill its consumer protection responsibilities in accordance with the Vaporized Nicotine and Non-Nicotine Products Regulation Act (RA 11900), on the regulation of nicotine and non-nicotine products. The DTI will also regularly update the list of permit holders for public safety, which will benefit both industry stakeholders and the general public in accessing information.

 

After 2Firrsts conducting research, it was found that the recently popular "Tuklaw" tobacco in the Philippines originates from the mountainous regions of Vietnam, with extremely high nicotine content and often containing synthetic cannabinoids. As a result, Philippine regulatory authorities have issued a warning that this product may lead to serious health risks such as epileptic seizures and hallucinations.

 

Image source: Department of Trade and Industry (DTI) of the Philippines.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
Turning Point Brands, a U.S. nicotine and tobacco-related consumer products company, reported its fiscal 2025 fourth-quarter results: quarterly revenue was $121 million, up 29% year over year; adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) was $30 million, up 14%. Net revenue from modern oral nicotine products was $41.3 million, up 266% year over year.
Mar.03 by 2FIRSTS.ai
Ireland Vape Retailers’ Group RVI Calls for Tax Stamps to Strengthen Enforcement of Vape Products Tax
Ireland Vape Retailers’ Group RVI Calls for Tax Stamps to Strengthen Enforcement of Vape Products Tax
Responsible Vaping Ireland (RVI), an Irish vape retailers’ group, has released a policy paper urging Ireland to swiftly introduce Revenue-issued tax stamps on vaping products to strengthen enforcement of the E-Liquid Products Tax (EPT) and to tackle tax evasion and the illicit market. Provisional Department of Finance figures show €1.3 million collected in November and December 2025; at that pace, annualised receipts would be €7.8 million, below the government’s projected €17 million.
Feb.26 by 2FIRSTS.ai
Imperial Brands to Close Langenhagen Cigarette Factory by 2027
Imperial Brands to Close Langenhagen Cigarette Factory by 2027
Imperial Brands said it will gradually close the Reemtsma factory in Langenhagen near Hanover by 2027 after efforts to find a buyer failed to produce a sustainable agreement. The factory has produced cigarettes since 1971 and currently affects around 600 employees. The company said it had examined all realistic options over recent months but did not receive a binding offer from a potential buyer.
Mar.27 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
Tamarind Intelligence’s decision to appoint a technology-sector executive as chief executive officer signals more than a leadership reshuffle at a specialist data firm. It reflects a broader structural shift across the global nicotine industry, where companies, regulators and intelligence providers are embedding artificial intelligence into core operations.
Special Report
Feb.18
Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
E-cigarette brand IVG has recently rolled out the IVG Pro 2 across several UK online retailers. The device is compatible with IVG Pro pods and comes in 33 flavours with nicotine strengths of 0mg, 10mg and 20mg. Channel listings show a 2ml prefilled pod paired with a 10ml refill container, with pricing around £9.99.
Feb.02 by 2FIRSTS.ai